Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae

被引:81
作者
Balsalobre, L
Ferrándiz, MJ
Liñares, J
Tubau, F
de la Carnpa, AG [1 ]
机构
[1] Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Inst Salud Carlos III, CSIC, Unidad Genet Bacteriana, Madrid 28220, Spain
[2] Bellvitge Hosp, Barcelona, Spain
关键词
D O I
10.1128/AAC.47.7.2072-2081.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
A total of 46 ciprofloxacin-resistant (Cip(r)) Streptococcus pneumoniae strains were isolated from 1991 to 2001 at the Hospital of Bellvitge. Five of these strains showed unexpectedly high rates of nucleotide variations in the quinolone resistance-determining regions (QRDRs) of their parC, parE, and gyrA genes. The nucleotide sequence of the full-length parC, parE, and gyrA genes of one of these isolates revealed a mosaic structure compatible with an interspecific recombination origin. Southern blot analysis and nucleotide sequence determinations showed the presence of an ant-like gene in the intergenic parE-parC regions of the S. pneumoniae Cipr isolates with high rates of variations in their parE and parC QRDRs. The ant-like gene was absent from typical S. pneumoniae strains, whereas it was present in the intergenic parE-parC regions of the viridans group streptococci (Streptococcus mitis and Streptococcus oralis). These results suggest that the viridans group streptococci are acting as donors in the horizontal transfer of fluoroquinolone resistance genes to S. pneumoniae.
引用
收藏
页码:2072 / 2081
页数:10
相关论文
共 57 条
[1]
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients [J].
Alcaide, F ;
Carratala, J ;
Linares, J ;
Gudiol, F ;
Martin, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :2117-2120
[2]
IN-VITRO ACTIVITIES OF 22-BETA-LACTAM ANTIBIOTICS AGAINST PENICILLIN-RESISTANT AND PENICILLIN-SUSCEPTIBLE VIRIDANS GROUP STREPTOCOCCI ISOLATED FROM BLOOD [J].
ALCAIDE, F ;
LINARES, J ;
PALLARES, R ;
CARRATALA, J ;
BENITEZ, MA ;
GUDIOL, F ;
MARTIN, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2243-2247
[3]
[Anonymous], STREPTOCOCCUS PNEUMO
[4]
STREPTOCOCCAL AND ENTEROCOCCAL BACTEREMIA IN PATIENTS WITH CANCER [J].
AWADA, A ;
VANDERAUWERA, P ;
MEUNIER, F ;
DANEAU, D ;
KLASTERSKY, J .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :33-48
[5]
Molecular characterization of the gene encoding the DNA gyrase a subunit of Streptococcus pneumoniae [J].
Balas, D ;
Fernández-Moreira, E ;
De la Campa, AG .
JOURNAL OF BACTERIOLOGY, 1998, 180 (11) :2854-2861
[6]
Community-acquired pneumonia in adults: Guidelines for management [J].
Bartlett, JG ;
Breiman, RF ;
Mandell, LA ;
File, TM .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :811-838
[7]
Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae [J].
Bast, DJ ;
de Azavedo, JCS ;
Tam, TY ;
Kilburn, L ;
Duncan, C ;
Mandell, LA ;
Davidson, RJ ;
Low, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2631-2634
[8]
BACTEREMIA DUE TO VIRIDANS STREPTOCOCCUS IN NEUTROPENIC PATIENTS WITH CANCER - CLINICAL SPECTRUM AND RISK-FACTORS [J].
BOCHUD, PY ;
EGGIMAN, P ;
CALANDRA, T ;
VANMELLE, G ;
SAGHAFI, L ;
FRANCIOLI, P .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) :25-31
[9]
BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI THAT ARE HIGHLY RESISTANT TO PENICILLIN - INCREASE AMONG NEUTROPENIC PATIENTS WITH CANCER [J].
CARRATALA, J ;
ALCAIDE, F ;
FERNANDEZSEVILLA, A ;
CORBELLA, X ;
LINARES, J ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1169-1173
[10]
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239